Cleared Traditional

K093837 - ATHENA MULTI-LYTE TREPONEMA PALLIDUM IG...

K093837 is an FDA 510(k) clearance for ATHENA MULTI-LYTE TREPONEMA PALLIDUM IG..., manufactured by Zeus Scientific, Inc. (Zeus). The device is a Class 2 Microbiology device with product code LIP cleared through the Traditional 510(k) pathway after a 290-day FDA review.

K093837 · Zeus Scientific, Inc. (Zeus) · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2010
Decision
290d
Days
Class 2
Risk

K093837 is an FDA 510(k) clearance for the ATHENA MULTI-LYTE TREPONEMA PALLIDUM IGG PLUS TEST SYSTEM. Classified as Enzyme Linked Immunoabsorption Assay, Treponema Pallidum (product code LIP), Class II - Special Controls.

Submitted by Zeus Scientific, Inc. (Zeus) (Raritan, US). The FDA issued a Cleared decision on October 1, 2010 after a review of 290 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3830 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Zeus Scientific, Inc. (Zeus) devices

FDA 510(k) Submission Details - K093837

510(k) Number K093837 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 15, 2009
Decision Date October 01, 2010
Days to Decision 290 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
188d slower than avg
Panel avg: 102d · This submission: 290d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIP Device Classification - Class 2, Special Controls

Product Code LIP Enzyme Linked Immunoabsorption Assay, Treponema Pallidum
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LIP Enzyme Linked Immunoabsorption Assay, Treponema Pallidum

All 19
Devices cleared under the same product code (LIP) and FDA review panel - the closest regulatory comparables to K093837.
BIOPLEX 2200 EBV IGG AND SYPHILIS IGG
K120439 · Bio-Rad Laboratories, Inc. · Mar 2012
TREPONEMA PALLIDUM TREPONEMAL TEST REAGENTS
K112343 · Siemens Healthcare Diagnostics, Inc. · Jan 2012
ZEUS SCIENTIFIC, INC. TREPONEMA PALLIDUM IGG TEST SYSTEM
K102283 · Zeus Scientific, Inc. · Feb 2011
IMMULITE 2000 SYPHILIS SCREEN TEST SYSTEM
K091361 · Siemens Healthcare Diagnostics · Dec 2009
BIOPLEX 2200 SYPHILIS IGG KIT ON THE BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM
K063866 · Bio-Rad Laboratories · Mar 2007
DIASORIN LIAISON TREPONEMA ASSAY
K061247 · DiaSorin, Inc. · Jul 2006